Genomed S.A., 02-971 Warsaw, Poland.
Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
Genes (Basel). 2024 Aug 1;15(8):1011. doi: 10.3390/genes15081011.
We present the results of the first study of a large cohort of patients with inherited retinal dystrophies (IRD) performed for the Polish population using whole-exome sequencing (WES) in the years 2016-2019. Moreover, to facilitate such diagnostic analyses and enable future application of gene therapy and genome editing for IRD patients, a Polish genomic reference database (POLGENOM) was created based on whole-genome sequences of healthy Polish Caucasian nonagenarians and centenarians. The newly constructed database served as a control, providing a comparison for variant frequencies in the Polish population. The diagnostic yield for the selected group of IRD patients reached 64.9%. The study uncovered the most common pathogenic variants in and in the European population, along with several novel causative variants. A significant frequency of the complex haplotype p.(Leu541Pro; Ala1038Val) was observed, as well as that of the p.Gly1961Glu variant. The first causative variant NM_004385.5:c.4004-2A>G in Poland was found and described. Moreover, one of the first patients with the causative variants was identified, and, in consequence, could receive the dedicated gene therapy. The availability of the reference POLGENOM database enabled comprehensive variant characterisation during the NGS data analysis, confirming the utility of a population-specific genomic database for enhancing diagnostic accuracy. Study findings suggest the significance of genetic testing in elder patients with unclear aetiology of eye diseases. The combined approach of NGS and the reference genomic database can improve the diagnosis, management, and future treatment of IRDs.
我们呈现了 2016 年至 2019 年期间,使用外显子组测序(WES)对波兰人群进行的首例大型遗传性视网膜病变(IRD)患者队列研究结果。此外,为了促进此类诊断分析,并为 IRD 患者未来的基因治疗和基因组编辑应用提供便利,我们基于健康波兰白种人 90 岁以上和百岁以上个体的全基因组序列,创建了波兰基因组参考数据库(POLGENOM)。新构建的数据库可用作对照,为波兰人群中的变异频率提供比较。对选定的 IRD 患者组的诊断率达到了 64.9%。该研究揭示了在欧洲人群中最常见的 和 致病变体,以及几个新的致病变体。观察到 复合杂合子 p.(Leu541Pro; Ala1038Val) 和 p.Gly1961Glu 变体的显著频率。在波兰首次发现了 NM_004385.5:c.4004-2A>G 致病变体,并进行了描述。此外,还鉴定了首例携带 致病变体的患者,因此可以接受专门的基因治疗。参考 POLGENOM 数据库的可用性使得在 NGS 数据分析期间能够全面进行变异特征分析,证实了针对特定人群的基因组数据库在提高诊断准确性方面的实用性。研究结果表明,在病因不明的老年眼病患者中进行基因检测具有重要意义。NGS 和参考基因组数据库的联合方法可以改善 IRD 的诊断、管理和未来治疗。